28bio
PrivateLast Round
Pre-Series A3
Jun 24, 2025
Est. Valuation
$20.01M
Total Funding Raised
$9.03M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
28bio is a neurotechnology company that provides a platform to engineer human brain and nerve models for accelerating drug discovery for neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Biotech Equipment, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
28bio Comparables
Compare 28bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emulate | 85% | |
| Hesperos Inc. | 83% | |
| Synaxys | 82% | |
28bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre-Series A3 | Jun 24, 2025 | ||||
| Series A Extension | Jun 10, 2021 | ||||
| Grant | Nov 2, 2020 | ||||
| Seed | Jun 15, 2020 | ||||
| Grant | Sep 21, 2017 | ||||
Pre Seed | Aug 3, 2017 |
28bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Orleans Startup Fund | Pre Seed |
| NIH RADx | Grant |
| Benson Capital Partners | Seed |
| Congressionally Directed Medical Research Programs | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 5, 2.1x the trailing average.
- Apr 16, 2026
Monthly visitors increased 406% MoM, from 422 to 2.1K.
28bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 28bio's valuation, stock price, and market status.